Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: Outcomes following a shortened 6-week protocol

BJU International

Volumn 106, Issue 11, 2010, Pages 1673-1676

  Yoong, Wai ^a   Ridout, Alexandra E ^b   Damodaram, Mellisa ^c   Dadswell, Rosemary ^a  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

incontinence; neuromodulation; overactive bladder syndrome; percutaneous tibial nerve stimulation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; DETRUSOR DYSSYNERGIA; FEMALE; HUMAN; INCONTINENCE IMPACT QUESTIONNAIRE; NERVE STIMULATION; NEUROMODULATION; OBSERVATIONAL STUDY; OVERACTIVE BLADDER; PERCUTANEOUS TIBIAL NERVE STIMULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SYMPTOM; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URGE INCONTINENCE; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; TIBIAL NERVE; TIME FACTORS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE; URODYNAMICS; YOUNG ADULT;

EID: 78649296790     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09461.x     Document Type: Article

References (17)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167 - 78
2. Herbison P, Hay-Smith J, Ellis G, Moore K,. Effectiveness of anticholinergic drugs compared to placebo in the treatment of overactive bladder: systematic review. BMJ 2003; 326: 841 - 4
3. Chapple CR, Cardozo L, Steers WD, Govier FE,. Solifenacin significantly improves all symptoms of overactive bladder syndrome. Int J Clin Pract 2006; 60: 959 - 66
4. Groen J, Bosch JL,. Neuromodulative techniques in the treatment of the overactive bladder. BJU Int 2001; 87: 723 - 31
5. McGuire EJ, Zhang SC, Horwinski ER, Lytton B,. Treatment of motor and sensory detrusor instability by electric stimulation. J Urol 1983; 129: 78 - 9
6. Govier FE, Litwiller S, Nitti V, Kreder KJ Jr, Rosenblatt P,. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol 2001; 165: 1193 - 8
7. Van Balken MR, Vandoninck V, Gisolf KW, et al. Posterior tibial nerve stimulation as a neuromodulative treatment of lower urinary tract dysfunction. J Urol 2001; 166: 914 - 8
8. Vandoninck V, Van Balken MR, Agro EF, et al. Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol Urodyn 2003; 22: 17 - 23
9. Shumaker SA, Wyman JF, Uebersac JS, McClish D, Fantl JA,. Health related quality of life measures for women with urinary incontinence: the Urogenital Distress Inventory and the Incontinence Impact Questionnaire. Qual Life Res 1994; 3: 291 - 306
10. Stoller M,. Afferent nerve stimulation for pelvic floor dysfunction. Eur Urol 1999; 35 (Suppl. 2): 16
11. Wang Y, Hassouna MM,. Neuromodulation reduces c-fos gene expression in spinalized rats: a double-blind randomized study. J Urol 2000; 163: 1966 - 70
12. Bower WF, Moore KH, Adams RD, Sheperd R,. A urodynamic study of surface neuromodulation versus sham in detrusor instability and sensory urgency. J Urol 1998; 160: 2133 - 6
13. Klingler HC, Pycha A, Schmidbauer J, Marberger M,. Use of peripheral neuromodulation of the S3 regions for treatment of detrusor overactivity: a urodynamic based study. Urology 2000; 56: 766 - 71
14. Karademir K, Baykal K, Sen B, Senkul T, Iseri C, Erden D,. A peripheric neuromodulation technique for curing detrusor overactivity: stoller afferent neurostimulation. Scand J Urol Nephr 2005; 39: 230 - 3
15. Peters KM, Macdiarmid SA, Wooldridge LS, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the Overactive Bladder Innovative Therapy Trial. J Urol 2009; 182: 1055 - 61
16. Van Der Pal F, Van Balken MR, Heesakkers JP, Debruyne FM, Bemelmans BL,. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary? BJU Int 2006; 97: 547 - 90
17. Robinson D, Jacklin P, Cardozo L,. Is cost the Achilles' heel of posterior tibial nerve stimulation? A cost minimisation comparison with antimuscarinic therapy in the management of OAB. Abstract poster presentation, International Continence Society 2009. Available at:. Accessed May 2010